GlassScriptPhysician profile
Gina Dado
NPI 1730146648
$545.61
in general payments reported to CMS, 2019-2025
14 companies · $251 in 2025
The $251 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $13.68 · 2020: $14.60 · 2021: $44.18 · 2022: $56.28 · 2024: $166 · 2025: $251.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $417.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $416.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sage Therapeutics, LLC | $109.93 | 2024-2025 | Zurzuvae |
| Boston Scientific Corporation | $88.47 | 2024 | Solyx Sis System |
| Hologic Sales and Service, LLC | $82.46 | 2021-2024 | Fluent Fluid Management System |
| Astellas Pharma US INC | $62.19 | 2025 | Veozah |
| Medtronic, INC. | $37.21 | 2025 | Ligasure, Truclear |
| Exeltis, USA INC. | $33.59 | 2025 | Slynd |
| Pfizer INC. | $23.55 | 2024 | |
| Abbvie INC. | $19.61 | 2022 | |
| Smith+Nephew, INC. | $18.52 | 2025 | Pico |
| Olympus America INC. | $15.31 | 2025 | Olympus |
| Merck Sharp & Dohme LLC | $14.60 | 2020 | |
| Abiomed | $13.68 | 2019 | |
| Organon LLC | $13.43 | 2025 | Jada System |
| Ethicon US, LLC | $13.06 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gina Dado listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.